Artemis Therapeutics Inc. announced earnings results for the first quarter ended March 31, 2021. For the first quarter, the company announced operating loss was USD 35,000 compared to USD 19,000 a year ago. Net loss was USD 36,000 compared to USD 21,000 a year ago. Basic loss per share from continuing operations was USD 0.006 compared to USD 0.003 a year ago.